Florence, January 28, 2025
Prevention saves lives
When the business world collaborates with organizations dedicated to the fight against cancer, the results can make a real difference. Hospitex, a leading company in oncology diagnostics, and LILT Florence, the Italian League for the Fight Against Cancer – Florence Provincial Association, announce a new joint campaign to prevent urinary tract tumors, including those of the bladder, kidneys, ureter, and urethra.
The initiative, launched as a pilot project, aims to raise public awareness of the importance of early diagnosis and offer innovative tools for prevention. At the center of the campaign is Urine24, the advanced diagnostic kit developed by Hospitex, which quickly identifies potential warning signs of urinary tract cancers, with bladder cancer being the most common.
Urine24 is extremely easy to use
The kit is shipped directly to the patient’s home, allowing them to collect urine samples conveniently by following the provided instructions. Subsequently, a courier collects the samples and delivers them to the analysis laboratory, where they are processed within 24 hours of receipt. The results are then emailed directly to the patient, ensuring a fast, secure, and discreet service.
Early diagnosis is a critical factor in the fight against bladder cancer. Detecting the disease in its early stages significantly increases the chances of recovery: clinical studies show that when cancer is diagnosed promptly, the likelihood of effective treatment and long-term survival can exceed 80%. Conversely, late diagnosis often results in advanced-stage disease, requiring more complex treatments and offering less favorable prognoses.
Through this campaign, Hospitex and LILT Florence aim to highlight the importance of regular check-ups and prevention as the first steps to safeguarding health. The primary target audience of this initiative is individuals over 50 years old, with a special focus on men. Additionally, it targets smokers, those with a family history of bladder cancer, and individuals exposed to pollutants under the age of 50. This focus stems from evidence that these groups face higher risks and can benefit significantly from screening and early diagnosis programs.
A portion of the proceeds from the sale of Urine24 will be donated to LILT Florence, directly supporting the association’s activities for prevention and patient care.
“We are proud to support an organization like LILT”, said Alessandro Nosei, General Manager of Hospitex. “Our mission is to provide effective tools for early diagnosis, helping to save lives through prevention.”
“This initiative is a concrete example of how important synergies can be when it comes to prevention: every component of society must do its part to build a better future for our healthcare and our health”, added Alexander Peirano, President of LILT Florence.
The pilot project includes an initial phase of distributing the Urine24 kit as part of LILT Florence’s screening and prevention activities, with the aim of later expanding its use. The campaign seeks to raise public awareness about the importance of taking care of one’s health, especially concerning oncological diseases that can be successfully managed through early diagnosis.
About Hospitex International
Hospitex International is an Italian company and a leader in oncology diagnostics. With a constant commitment to research and development, Hospitex serves as a reference point in the field of advanced medical technologies.
About LILT Florence
The Italian League for the Fight Against Cancer – Florence Provincial Association has been active in the Florence area for 100 years, focusing on information, prevention, early diagnosis, home care, and oncological rehabilitation.
For more information about the initiative:
Hospitex: www.hospitex.com
LILT Florence: www.legatumorifirenze.it
